SLC5A2 and cardiovascular disorder: In face of the results of outcome studies showing cardiovascular risk reductions with SGLT2 inhibitors, it would be of particular interest to further investigate the association between genetic variation at the SLC5A2 gene locus and cardiovascular disease in larger study cohorts in order to definitely clarify this issue.